|
humans |
52 |
|
female |
47 |
|
hong kong |
42 |
|
male |
39 |
|
middle aged |
39 |
|
adult |
38 |
|
aged |
37 |
|
hong kong - epidemiology |
30 |
|
adolescent |
29 |
|
child |
29 |
|
risk factors |
28 |
|
cohort studies |
23 |
|
aged, 80 and over |
21 |
|
child, preschool |
21 |
|
prevalence |
20 |
|
medical sciences |
18 |
|
age factors |
17 |
|
china |
17 |
|
infant |
16 |
|
influenza |
16 |
|
incidence |
15 |
|
logistic models |
14 |
|
questionnaires |
14 |
|
risk assessment |
14 |
|
socioeconomic factors |
14 |
|
breast cancer |
13 |
|
cross-sectional studies |
13 |
|
disease outbreaks |
13 |
|
sars |
13 |
|
young adult |
13 |
|
antibodies, viral - blood |
12 |
|
antigens, cd - genetics |
12 |
|
children |
12 |
|
epidemiologic methods |
12 |
|
follow-up studies |
12 |
|
longitudinal studies |
12 |
|
mortality |
12 |
|
odds ratio |
12 |
|
severe acute respiratory syndrome - blood - genetics |
12 |
|
time factors |
12 |
|
attitude of health personnel |
11 |
|
chinese |
11 |
|
communicable disease control - methods |
11 |
|
decision making |
11 |
|
family characteristics |
11 |
|
polymorphism, single nucleotide |
11 |
|
registries |
11 |
|
retrospective studies |
11 |
|
severe acute respiratory syndrome |
11 |
|
transmission |
11 |
|
age distribution |
10 |
|
body mass index |
10 |
|
coronavirus disease 2019 |
10 |
|
family health |
10 |
|
immunity |
10 |
|
infant, newborn |
10 |
|
prospective studies |
10 |
|
puberty |
10 |
|
vaccination |
10 |
|
breastfeeding |
9 |
|
cataract |
9 |
|
cervical cancer |
9 |
|
chemicals and cas registry numbers |
9 |
|
cost-benefit analysis |
9 |
|
demography |
9 |
|
disease transmission |
9 |
|
eye diseases |
9 |
|
growth |
9 |
|
models, statistical |
9 |
|
sars virus - immunology |
9 |
|
screening |
9 |
|
smoking |
9 |
|
visual impairment |
9 |
|
adolescents |
8 |
|
age-period-cohort |
8 |
|
attitude to health |
8 |
|
behavior change |
8 |
|
bioaerosol |
8 |
|
breast feeding |
8 |
|
cardiovascular disease |
8 |
|
cell adhesion molecules - genetics |
8 |
|
cell adhesion molecules - genetics - physiology |
8 |
|
china - epidemiology |
8 |
|
confidence intervals |
8 |
|
coughing |
8 |
|
disease predisposition |
8 |
|
disease surveillance |
8 |
|
education, medical, undergraduate - methods |
8 |
|
genetic predisposition to disease |
8 |
|
health knowledge, attitudes, practice |
8 |
|
hospitalization |
8 |
|
human exhaled breath |
8 |
|
incidence rates |
8 |
|
influenza virus |
8 |
|
lectins, c-type - genetics |
8 |
|
mask |
8 |
|
pandemic |
8 |
|
pregnancy |
8 |
|
quarantine |
8 |
|
receptors, cell surface - genetics |
8 |
|
sars virus - isolation and purification - pathogenicity |
8 |
|
severe acute respiratory syndrome - physiopathology - virology |
8 |
|
social class |
8 |
|
treatment outcome |
8 |
|
acute bed day use |
7 |
|
analysis of variance |
7 |
|
antibody |
7 |
|
antiviral agents - therapeutic use |
7 |
|
asian continental ancestry group - genetics |
7 |
|
asian continental ancestry group - statistics & numerical data |
7 |
|
attitude to computers |
7 |
|
breast neoplasms - epidemiology |
7 |
|
case-control studies |
7 |
|
cd209 |
7 |
|
cell adhesion molecules - genetics - metabolism |
7 |
|
child development |
7 |
|
communicable diseases, emerging - prevention and control - transmission |
7 |
|
coronavirus - immunology |
7 |
|
curriculum |
7 |
|
dc-sign |
7 |
|
dna - metabolism |
7 |
|
dna probes - genetics |
7 |
|
education |
7 |
|
electrophoretic mobility shift assay |
7 |
|
evidence-based medicine - education |
7 |
|
evidence-based medicine/*education |
7 |
|
gene frequency - genetics |
7 |
|
genotype |
7 |
|
health care surveys |
7 |
|
health status |
7 |
|
health status disparities |
7 |
|
hela cells |
7 |
|
heterozygote |
7 |
|
homozygote |
7 |
|
hospitals - utilization |
7 |
|
infection control |
7 |
|
influenza a virus - classification - genetics |
7 |
|
influenza a virus, h7n9 subtype |
7 |
|
influenza in birds - prevention and control - transmission |
7 |
|
influenza in birds - transmission - virology |
7 |
|
influenza, human - prevention and control - transmission |
7 |
|
influenza, human - transmission - virology |
7 |
|
l-lactate dehydrogenase - blood |
7 |
|
lactate dehydrogenase |
7 |
|
last years of life |
7 |
|
lectins, c-type - genetics - metabolism |
7 |
|
length of stay - statistics & numerical data |
7 |
|
migration |
7 |
|
models, theoretical |
7 |
|
molecular sequence data |
7 |
|
nose - virology |
7 |
|
nuclear proteins - metabolism |
7 |
|
obesity |
7 |
|
obesity - epidemiology |
7 |
|
orthomyxoviridae - isolation & purification |
7 |
|
pandemics |
7 |
|
patient satisfaction |
7 |
|
pharynx - virology |
7 |
|
phylogeny |
7 |
|
physicians - psychology |
7 |
|
poisson distribution |
7 |
|
polymorphism, single nucleotide - genetics |
7 |
|
predictive value of tests |
7 |
|
promoter regions, genetic - genetics |
7 |
|
proportional hazards models |
7 |
|
protein binding - genetics |
7 |
|
public health |
7 |
|
receptors, cell surface - genetics - metabolism |
7 |
|
regression analysis |
7 |
|
reverse transcriptase polymerase chain reaction |
7 |
|
sars-coronavirus seroprevalence |
7 |
|
seroepidemiologic studies |
7 |
|
severe acute respiratory syndrome - blood - epidemiology |
7 |
|
severe acute respiratory syndrome - epidemiology - transmission |
7 |
|
sex factors |
7 |
|
smoking - epidemiology |
7 |
|
snp |
7 |
|
socioeconomic position |
7 |
|
sp1 transcription factor - genetics |
7 |
|
survival rate |
7 |
|
terminally ill |
7 |
|
transcription factor ap-2 - genetics |
7 |
|
transfection |
7 |
|
waiting lists |
7 |
|
access to care |
6 |
|
aging - physiology |
6 |
|
antibodies, neutralizing - blood |
6 |
|
asian continental ancestry group - statistics and numerical data |
6 |
|
attitude |
6 |
|
birth weight |
6 |
|
blood pressure |
6 |
|
body height |
6 |
|
body height - physiology |
6 |
|
cholesterol, hdl - blood |
6 |
|
clinical competence *standards |
6 |
|
cluster analysis |
6 |
|
computer-assisted learning |
6 |
|
computers, handheld - trends |
6 |
|
contact tracing |
6 |
|
cost-effectiveness analysis |
6 |
|
cross infection - epidemiology - prevention & control - transmission |
6 |
|
cross protection |
6 |
|
databases as topic |
6 |
|
decision support systems, clinical - instrumentation |
6 |
|
diabetes mellitus - epidemiology |
6 |
|
disease outbreaks - prevention & control - statistics & numerical data |
6 |
|
disease outbreaks - prevention and control |
6 |
|
disease outbreaks - statistics & numerical data |
6 |
|
disease progression |
6 |
|
education, medical, undergraduate/*methods |
6 |
|
emergency service, hospital |
6 |
|
emigration and immigration |
6 |
|
gestational age |
6 |
|
health services - utilization |
6 |
|
health services accessibility |
6 |
|
health services research |
6 |
|
health status indicators |
6 |
|
hemagglutination inhibition tests |
6 |
|
human |
6 |
|
hypertension |
6 |
|
immunoglobulin g - blood |
6 |
|
influenza a virus |
6 |
|
influenza b virus |
6 |
|
influenza in birds - mortality - transmission |
6 |
|
influenza vaccines - administration & dosage - immunology |
6 |
|
influenza, human - epidemiology - prevention & control - virology |
6 |
|
influenza, human - mortality |
6 |
|
learning/methods |
6 |
|
likelihood functions |
6 |
|
linear models |
6 |
|
mathematics |
6 |
|
menarche |
6 |
|
mendelian randomization |
6 |
|
morbidity |
6 |
|
multivariate analysis |
6 |
|
neutralization tests |
6 |
|
patient isolation |
6 |
|
placebos - administration & dosage |
6 |
|
population surveillance |
6 |
|
probability |
6 |
|
public health practice |
6 |
|
public sector |
6 |
|
quarantine - methods - statistics & numerical data |
6 |
|
reference values |
6 |
|
resource allocation |
6 |
|
respiration, artificial - statistics and numerical data |
6 |
|
respiration-disorders-etiology |
6 |
|
rna, viral - genetics - isolation & purification |
6 |
|
sars virus - physiology |
6 |
|
severe acute respiratory syndrome - diagnosis |
6 |
|
severe acute respiratory syndrome - diagnosis - epidemiology |
6 |
|
severe acute respiratory syndrome - epidemiology |
6 |
|
severe acute respiratory syndrome - epidemiology - prevention & control - transmission - virology |
6 |
|
sex distribution |
6 |
|
smoking-adverse-effects |
6 |
|
stochastic processes |
6 |
|
students, medical - psychology |
6 |
|
tobacco-smoke-pollution-adverse-effects |
6 |
|
vaccination - methods |
6 |
|
vaccines, inactivated - administration & dosage - immunology |
6 |
|
victoria lineage |
6 |
|
viral shedding |
6 |
|
willingness-to-pay |
6 |
|
world health |
6 |
|
yamagata lineage |
6 |
|
adiposity |
5 |
|
adolescent behavior - ethnology - psychology |
5 |
|
alcohol drinking - adverse effects - mortality |
5 |
|
ambulatory care - utilization |
5 |
|
ambulatory care facilities |
5 |
|
anthropometry - methods |
5 |
|
antibody response |
5 |
|
basic reproduction number |
5 |
|
blood glucose - analysis |
5 |
|
body weight - physiology |
5 |
|
breast cancer screening |
5 |
|
breast feeding - statistics & numerical data |
5 |
|
breast neoplasms - diagnosis - prevention & control |
5 |
|
cardiovascular diseases - epidemiology - etiology |
5 |
|
case-control |
5 |
|
cesarean section - adverse effects |
5 |
|
child health services - utilization |
5 |
|
china - ethnology |
5 |
|
chinese culture |
5 |
|
cholesterol |
5 |
|
clinical clerkship |
5 |
|
clinical clerkships |
5 |
|
clinical computerization |
5 |
|
cognition |
5 |
|
cognition - physiology |
5 |
|
cohort study |
5 |
|
computer systems - economics |
5 |
|
computerization |
5 |
|
contingent valuation |
5 |
|
control |
5 |
|
controlled study |
5 |
|
covid-19 |
5 |
|
credible interval |
5 |
|
culture |
5 |
|
curriculum/ *standards |
5 |
|
dalys |
5 |
|
decision aid |
5 |
|
diabetes mellitus |
5 |
|
diabetes mellitus - epidemiology - etiology |
5 |
|
diet |
5 |
|
diet - adverse effects - statistics & numerical data |
5 |
|
disease control |
5 |
|
disease severity |
5 |
|
dynamics |
5 |
|
economic conditions |
5 |
|
education, medical, undergraduate - standards |
5 |
|
education, medical, undergraduate/*standards |
5 |
|
educational measurement |
5 |
|
educational status |
5 |
|
enzyme linked immunosorbent assay |
5 |
|
estrogens - physiology |
5 |
|
evidence based medicine/*education |
5 |
|
evidence-based medicine |
5 |
|
excess mortality |
5 |
|
focus groups |
5 |
|
food habits |
5 |
|
fruit |
5 |
|
genetic difference |
5 |
|
gtp-binding proteins - genetics - immunology |
5 |
|
h1n1pdm09 |
5 |
|
health behavior |
5 |
|
health personnel |
5 |
|
health surveys |
5 |
|
health surveys - methods |
5 |
|
hong kong chinese |
5 |
|
horizontal equity |
5 |
|
hospital administration |
5 |
|
hospitalization - statistics & numerical data |
5 |
|
hyperlipidemias - epidemiology - etiology |
5 |
|
hypertension - epidemiology - etiology |
5 |
|
iatrogenesis |
5 |
|
iatrogenic disease - epidemiology |
5 |
|
illness |
5 |
|
immune response |
5 |
|
immunity, innate |
5 |
|
impact |
5 |
|
incentives |
5 |
|
individualism |
5 |
|
infant welfare |
5 |
|
infectious disease transmission, patient-to-professional |
5 |
|
infectiousness |
5 |
|
influenza, human - diagnosis - virology |
5 |
|
influenza, human - drug therapy - transmission - virology |
5 |
|
information systems - economics |
5 |
|
informed choice |
5 |
|
interferon-alpha - immunology |
5 |
|
interferon-beta - immunology |
5 |
|
interviews as topic |
5 |
|
life course epidemiology |
5 |
|
literature review |
5 |
|
longitudinal study |
5 |
|
mammography - economics |
5 |
|
markov chains |
5 |
|
mass screening - utilization |
5 |
|
maternal welfare |
5 |
|
medical history taking |
5 |
|
medical sciences public health and safety |
5 |
|
menopause |
5 |
|
metabolic syndrome x - diagnosis - epidemiology - etiology - physiopathology |
5 |
|
motivation |
5 |
|
motor activity - physiology |
5 |
|
myocardial ischemia - epidemiology - etiology |
5 |
|
non-attendance |
5 |
|
nonlinear dynamics |
5 |
|
older adults |
5 |
|
organizational innovation |
5 |
|
orthomyxoviridae - isolation and purification |
5 |
|
oseltamivir - therapeutic use |
5 |
|
patient acceptance of health care |
5 |
|
physical examination |
5 |
|
physician-patient relations |
5 |
|
physicians |
5 |
|
postmenopause - blood - psychology |
5 |
|
practice management - organization & administration |
5 |
|
prenatal exposure delayed effects - epidemiology |
5 |
|
private practice |
5 |
|
promoter regions, genetic |
5 |
|
puberty - physiology |
5 |
|
public health and safety |
5 |
|
questionnaires - economics |
5 |
|
randomized controlled trial |
5 |
|
references (9) view in table layout |
5 |
|
referral and consultation |
5 |
|
reimbursement mechanisms - economics - organization & administration |
5 |
|
reproducibility of results |
5 |
|
reproductive history |
5 |
|
response rates |
5 |
|
sars-cov-2 |
5 |
|
seafood |
5 |
|
selection bias |
5 |
|
self-assessment |
5 |
|
self-examination - methods |
5 |
|
self-rated health |
5 |
|
serial interval |
5 |
|
severe acute respiratory syndrome - genetics - immunology |
5 |
|
severity of illness index |
5 |
|
smoking - adverse effects - mortality |
5 |
|
smoking - mortality |
5 |
|
social environment |
5 |
|
social values - ethnology |
5 |
|
socio-economic status |
5 |
|
soy foods |
5 |
|
students, medical |
5 |
|
suicide |
5 |
|
suicide - ethnology |
5 |
|
surgical procedures, elective |
5 |
|
synergy |
5 |
|
tea |
5 |
|
testosterone |
5 |
|
tobacco smoke pollution - statistics & numerical data |
5 |
|
triglycerides - blood |
5 |
|
urban population - statistics & numerical data |
5 |
|
uterine cervical neoplasms - diagnosis - prevention & control |
5 |
|
vaccine |
5 |
|
values |
5 |
|
vegetables |
5 |
|
virus shedding |
5 |
|
world health organization |
5 |
|
95% ci |
4 |
|
95% confidence intervals |
4 |
|
adolescent development - physiology |
4 |
|
adrenal cortex hormones - therapeutic use |
4 |
|
alcohol drinking |
4 |
|
algorithms |
4 |
|
antigens, viral - analysis |
4 |
|
asia |
4 |
|
asian continental ancestry group |
4 |
|
attitudes |
4 |
|
birth |
4 |
|
birth cohort |
4 |
|
birth rate - trends |
4 |
|
blood glucose |
4 |
|
body fat distribution |
4 |
|
body mass |
4 |
|
body weights and measures |
4 |
|
bone development - physiology |
4 |
|
breast neoplasms - diagnosis - economics - ethnology |
4 |
|
breast neoplasms - ethnology |
4 |
|
breast neoplasms - ethnology - radiography |
4 |
|
breast neoplasms - prevention & control - radiotherapy - surgery - therapy |
4 |
|
canada - epidemiology |
4 |
|
cancer care |
4 |
|
cardiovascular diseases - blood - epidemiology - etiology - physiopathology |
4 |
|
cardiovascular diseases - epidemiology |
4 |
|
cardiovascular diseases - epidemiology - ethnology - etiology |
4 |
|
case-control study |
4 |
|
case-fatality ratio |
4 |
|
cause of death |
4 |
|
cesarean section - statistics & numerical data - trends |
4 |
|
cesarean section - utilization |
4 |
|
chickens - virology |
4 |
|
child development - physiology |
4 |
|
childhood overweight |
4 |
|
chronic obstructive pulmonary disease |
4 |
|
cognition disorders - diagnosis |
4 |
|
communicable diseases, emerging - epidemiology |
4 |
|
communicable diseases, emerging - mortality |
4 |
|
computer simulation |
4 |
|
contact tracing - methods |
4 |
|
copd |
4 |
|
corticosteroids |
4 |
|
cost effectiveness |
4 |
|
counseling - standards |
4 |
|
data collection |
4 |
|
data interpretation, statistical |
4 |
|
depression |
4 |
|
determinants |
4 |
|
developed countries |
4 |
|
developing countries |
4 |
|
diabetes |
4 |
|
diabetes mellitus, type 2 - epidemiology |
4 |
|
diagnostic tests |
4 |
|
directive counseling - organization & administration |
4 |
|
disease outbreaks - prevention & control |
4 |
|
doctor shopping |
4 |
|
drug administration schedule |
4 |
|
drug therapy, combination |
4 |
|
early detection of cancer - economics |
4 |
|
effectiveness |
4 |
|
emigrants and immigrants |
4 |
|
england - epidemiology |
4 |
|
epidemiology |
4 |
|
equity |
4 |
|
ethnic groups - statistics & numerical data |
4 |
|
european continental ancestry group - statistics & numerical data |
4 |
|
evaluation |
4 |
|
factor analysis, statistical |
4 |
|
fecal incontinence - prevention & control |
4 |
|
financing, personal |
4 |
|
health benefit plans, employee - economics - statistics & numerical data |
4 |
|
health care rationing - economics |
4 |
|
health insurance |
4 |
|
health services |
4 |
|
health services - standards |
4 |
|
health services needs and demand |
4 |
|
height |
4 |
|
hematocrit |
4 |
|
hemoglobin |
4 |
|
hemorrhagic |
4 |
|
hong kong - epidemiology - ethnology |
4 |
|
hospitals, maternity - statistics & numerical data - trends |
4 |
|
hospitals, private - standards |
4 |
|
hospitals, private - statistics & numerical data - trends |
4 |
|
hospitals, public - standards |
4 |
|
hospitals, public - statistics & numerical data - trends |
4 |
|
human influenza |
4 |
|
hypertension - blood - complications - epidemiology - etiology - physiopathology |
4 |
|
hypertriglyceridemia |
4 |
|
icd-9 |
4 |
|
immunoassay |
4 |
|
immunoassay - methods |
4 |
|
infant feeding |
4 |
|
infant growth |
4 |
|
infant growth trajectory |
4 |
|
infant, small for gestational age |
4 |
|
infection |
4 |
|
influenza a virus - genetics - immunology - isolation and purification |
4 |
|
influenza a virus - immunology - isolation and purification |
4 |
|
influenza a virus, h1n1 subtype - genetics - immunology - isolation and purification |
4 |
|
influenza b virus - immunology - isolation and purification |
4 |
|
influenza in birds - transmission |
4 |
|
influenza, human - epidemiology - transmission - virology |
4 |
|
influenza, human - prevention and control - psychology - transmission |
4 |
|
inpatients - psychology - statistics & numerical data |
4 |
|
insulin resistance |
4 |
|
insurance, health - economics - statistics & numerical data |
4 |
|
international classification of diseases |
4 |
|
kaplan-meier estimator |
4 |
|
l-lactate dehydrogenase |
4 |
|
leisure activities |
4 |
|
major clinical study |
4 |
|
mammography |
4 |
|
mammography - standards - utilization |
4 |
|
mammography - utilization |
4 |
|
mass screening - economics - methods |
4 |
|
mass screening - standards - utilization |
4 |
|
metabolic syndrome x - blood - complications - epidemiology - physiopathology |
4 |
|
metabolic syndrome x - blood - diagnosis |
4 |
|
metabolic syndrome x - complications - epidemiology |
4 |
|
metabolic syndrome x - epidemiology - ethnology - etiology |
4 |
|
metagenomics |
4 |
|
midwifery - standards |
4 |
|
milk |
4 |
|
models, biological |
4 |
|
monte carlo method |
4 |
|
moral hazard |
4 |
|
morals |
4 |
|
mortality - trends |
4 |
|
mothers |
4 |
|
motor activity |
4 |
|
myocardial ischemia |
4 |
|
myocardial ischemia - economics - etiology - mortality |
4 |
|
myocardial ischemia - physiopathology |
4 |
|
ninth revision |
4 |
|
nonattendance |
4 |
|
nonhuman |
4 |
|
nurses |
4 |
|
nurses - standards |
4 |
|
occupations |
4 |
|
ontario - epidemiology |
4 |
|
or |
4 |
|
overweight - epidemiology |
4 |
|
palliative care |
4 |
|
patient education as topic - methods |
4 |
|
pholidota (animal) |
4 |
|
physical activity |
4 |
|
policy making |
4 |
|
practice guidelines as topic |
4 |
|
prognosis |
4 |
|
projection |
4 |
|
propensity score |
4 |
|
puberty onset |
4 |
|
quality assurance, health care |
4 |
|
quality-adjusted life years |
4 |
|
randomized controlled trials as topic |
4 |
|
reagent kits, diagnostic |
4 |
|
references (20) view in table layout |
4 |
|
references (39) view in table layout |
4 |
|
registries - statistics & numerical data |
4 |
|
respiratory distress syndrome, adult - drug therapy - mortality |
4 |
|
ribavirin |
4 |
|
ribavirin - therapeutic use |
4 |
|
risk |
4 |
|
risk reduction behavior |
4 |
|
roc curve |
4 |
|
sars virus |
4 |
|
sensitivity |
4 |
|
sensitivity and specificity |
4 |
|
severe acute respiratory syndrome - epidemiology - mortality |
4 |
|
severe acute respiratory syndrome - mortality |
4 |
|
sex |
4 |
|
sleep duration |
4 |
|
smoking cessation |
4 |
|
smoking cessation - methods |
4 |
|
smoking cessation counseling |
4 |
|
social welfare - economics - statistics & numerical data |
4 |
|
social work - education |
4 |
|
social work - standards |
4 |
|
social workers |
4 |
|
specificity |
4 |
|
statistics, nonparametric |
4 |
|
stroke |
4 |
|
sugar-sweetened beverages |
4 |
|
survival analysis |
4 |
|
survival rate - trends |
4 |
|
training |
4 |
|
type 2 diabetes |
4 |
|
underlying risk factors |
4 |
|
viral load |
4 |
|
waist circumference |
4 |
|
waiting time |
4 |
|
wales - epidemiology |
4 |
|
women's health |
4 |
|
years of life lost |
4 |
|
absolute income |
3 |
|
adipose tissue - anatomy and histology |
3 |
|
adiposity - physiology |
3 |
|
adolescent behavior - psychology |
3 |
|
adolescent psychology |
3 |
|
alcohol |
3 |
|
alcohol drinking - epidemiology - mortality |
3 |
|
alcohol drinking - epidemiology - psychology |
3 |
|
alcohol drinking - ethnology |
3 |
|
alcohol use |
3 |
|
ambulatory care |
3 |
|
animals |
3 |
|
anticarcinogenic agents - pharmacology |
3 |
|
article |
3 |
|
asian continental ancestry group - psychology |
3 |
|
assessment |
3 |
|
asthma |
3 |
|
bayesian methods |
3 |
|
biological markers - blood |
3 |
|
birth rate |
3 |
|
birthweight |
3 |
|
blood glucose - metabolism |
3 |
|
bmi |
3 |
|
body composition |
3 |
|
breast - drug effects |
3 |
|
breast feeding - psychology |
3 |
|
breast neoplasms - chemically induced - prevention & control |
3 |
|
breast neoplasms - psychology |
3 |
|
cancer |
3 |
|
carcinogenicity tests - methods |
3 |
|
cardiovascular |
3 |
|
cardiovascular diseases - economics - mortality |
3 |
|
cervical intraepithelial neoplasia - diagnosis - epidemiology - prevention & control |
3 |
|
cesarean section |
3 |
|
chi-square distribution |
3 |
|
choice behavior |
3 |
|
chronic disease |
3 |
|
chronic obstructive pulmonary disease (copd) |
3 |
|
clinical vs. administrative tasks |
3 |
|
cognition disorders - ethnology |
3 |
|
coitus - psychology |
3 |
|
community-based medical education |
3 |
|
computer systems |
3 |
|
concentration curve |
3 |
|
consultation |
3 |
|
counseling - statistics & numerical data |
3 |
|
cross-sectional study |
3 |
|
delivery, obstetric - methods |
3 |
|
delivery, obstetric - statistics & numerical data |
3 |
|
depression - complications - epidemiology |
3 |
|
depression - diagnosis - epidemiology - ethnology |
3 |
|
depression - diagnosis - epidemiology - etiology |
3 |
|
depressive symptoms |
3 |
|
developing populations |
3 |
|
diabetes mellitus - epidemiology - psychology |
3 |
|
disease duration |
3 |
|
economic aspect |
3 |
|
economic development |
3 |
|
economic development - statistics & numerical data |
3 |
|
economic development - statistics and numerical data |
3 |
|
education, medical - standards |
3 |
|
efficiency |
3 |
|
elderly |
3 |
|
elderly care |
3 |
|
emigration and immigration - statistics & numerical data |
3 |
|
epidemic |
3 |
|
erratum |
3 |
|
error |
3 |
|
estradiol - pharmacology |
3 |
|
extraction, obstetrical - methods |
3 |
|
family |
3 |
|
family relations |
3 |
|
fasting - blood |
3 |
|
flutamide |
3 |
|
flutamide - pharmacology |
3 |
|
follow-up |
3 |
|
france |
3 |
|
gender dissatisfaction |
3 |
|
gender identity |
3 |
|
glucose |
3 |
|
gonadal steroid hormones |
3 |
|
gonadal steroid hormones - pharmacology |
3 |
|
government |
3 |
|
grandparental education |
3 |
|
gut microbiota |
3 |
|
health care cost |
3 |
|
health care personnel |
3 |
|
health expenditures |
3 |
|
health inequalities |
3 |
|
health policy |
3 |
|
health service |
3 |
|
health transition |
3 |
|
herd immunity |
3 |
|
hospitals, public |
3 |
|
human papillomavirus |
3 |
|
hygiene - education - standards |
3 |
|
immunization programs |
3 |
|
income - classification |
3 |
|
income inequality |
3 |
|
infant welfare - statistics & numerical data |
3 |
|
infection control - methods |
3 |
|
infectious disease control |
3 |
|
infectious disease epidemiology |
3 |
|
infectious disease transmission, vertical - prevention and control |
3 |
|
influenza vaccines |
3 |
|
influenza, human - drug therapy - prevention and control - transmission |
3 |
|
influenza, human - epidemiology - prevention and control - transmission |
3 |
|
influenza, human - prevention & control |
3 |
|
information systems |
3 |
|
intention to computerize |
3 |
|
intergenerational effects |
3 |
|
ischemic heart disease |
3 |
|
leg - anatomy and histology - growth and development |
3 |
|
letter |
3 |
|
life course |
3 |
|
life style |
3 |
|
long term care |
3 |
|
lung neoplasms - mortality |
3 |
|
mammary carcinogenesis |
3 |
|
masks - utilization |
3 |
|
mass screening |
3 |
|
maternal conditions |
3 |
|
maternal exposure |
3 |
|
mathematical model |
3 |
|
maximum likelihood estimation |
3 |
|
medical education |
3 |
|
mental recall |
3 |
|
metabolic syndrome |
3 |
|
metabolic syndrome x - blood - complications - epidemiology - etiology |
3 |
|
metabolism |
3 |
|
mismatch |
3 |
|
mixed medical economy |
3 |
|
models, econometric |
3 |
|
mothers - education - statistics & numerical data |
3 |
|
mothers - statistics & numerical data |
3 |
|
muscle mass |
3 |
|
muscle, skeletal |
3 |
|
myocardial ischemia - etiology |
3 |
|
myocardial ischemia - mortality |
3 |
|
neighbourhood |
3 |
|
neoplasms - economics - mortality |
3 |
|
obesity - epidemiology - psychology |
3 |
|
office visits - economics - utilization |
3 |
|
old |
3 |
|
older |
3 |
|
overweight |
3 |
|
parental education |
3 |
|
parents - psychology |
3 |
|
paternal exposure |
3 |
|
patient-centered care - methods |
3 |
|
patient-centred method |
3 |
|
peer group |
3 |
|
personal satisfaction |
3 |
|
physician |
3 |
|
pituitary adenoma |
3 |
|
pituitary gland - drug effects |
3 |
|
potential years of life lost |
3 |
|
practice management, medical - organization & administration |
3 |
|
predictors of computerisation |
3 |
|
prenatal exposure delayed effects |
3 |
|
private sector |
3 |
|
private sector - economics - utilization |
3 |
|
problem-based learning - methods |
3 |
|
problem-based learning - organization & administration |
3 |
|
prolactinoma - chemically induced - prevention & control |
3 |
|
puberty - psychology |
3 |
|
public health - education |
3 |
|
public health administration |
3 |
|
public health policy |
3 |
|
public health service |
3 |
|
public sector - economics - utilization |
3 |
|
rats |
3 |
|
referral and consultation - standards |
3 |
|
relative income |
3 |
|
residence characteristics - classification - statistics & numerical data |
3 |
|
respiratory protective devices - utilization |
3 |
|
same-sex attraction |
3 |
|
satisfaction |
3 |
|
school |
3 |
|
school health service |
3 |
|
self concept |
3 |
|
sex characteristics |
3 |
|
sex hormones |
3 |
|
sexual mixing |
3 |
|
sexuality |
3 |
|
sickness impact profile |
3 |
|
smoking - adverse effects - epidemiology |
3 |
|
smoking - epidemiology - ethnology |
3 |
|
social disparities |
3 |
|
social distance |
3 |
|
socio-economic status (ses) |
3 |
|
socioeconomic status |
3 |
|
tamoxifen |
3 |
|
tamoxifen - pharmacology |
3 |
|
testosterone - pharmacology |
3 |
|
tobacco smoke pollution |
3 |
|
tobacco smoke pollution - adverse effects - statistics & numerical data |
3 |
|
transients and migrants - statistics & numerical data |
3 |
|
type 2 diabetes mellitus |
3 |
|
united states |
3 |
|
united states dept. of health and human services |
3 |
|
urban health - classification - statistics & numerical data |
3 |
|
uterine cervical neoplasms - diagnosis - epidemiology - prevention & control |
3 |
|
value of life - economics |
3 |
|
viscera - anatomy and histology |
3 |
|
waist-hip ratio |
3 |
|
weight-related concerns |
3 |
|
wheeze |
3 |
|
actuarial analysis |
2 |
|
air microbiology - standards |
2 |
|
air movements |
2 |
|
airborne |
2 |
|
airflow |
2 |
|
antiviral drugs |
2 |
|
bayes theorem |
2 |
|
behaviour |
2 |
|
benchmarking - methods |
2 |
|
biometry |
2 |
|
budgets |
2 |
|
building |
2 |
|
catastrophic health payments |
2 |
|
catastrophic illness - economics |
2 |
|
central obesity |
2 |
|
communicable diseases - complications - epidemiology - virology |
2 |
|
communicable diseases - transmission |
2 |
|
computers, handheld |
2 |
|
cost sharing |
2 |
|
cross infection |
2 |
|
cross infection - epidemiology |
2 |
|
cross-cultural comparison |
2 |
|
decision support systems, clinical |
2 |
|
decomposition analysis |
2 |
|
delivery of health care |
2 |
|
delivery of health care - economics |
2 |
|
delivery of health care - economics - statistics & numerical data |
2 |
|
disease transmission, infectious - prevention & control |
2 |
|
education, medical |
2 |
|
empirical research |
2 |
|
epidemiologic studies |
2 |
|
evidence-based practice |
2 |
|
financing, personal - economics - statistics & numerical data |
2 |
|
forecasting |
2 |
|
hand hygiene |
2 |
|
health care financing |
2 |
|
health care reform |
2 |
|
health care utilization |
2 |
|
health expenditures - trends |
2 |
|
health services utilization |
2 |
|
hong kong - ethnology |
2 |
|
hospitals |
2 |
|
income-related inequality |
2 |
|
income-related inequity |
2 |
|
incubation times |
2 |
|
infection control - standards |
2 |
|
influenza, human - epidemiology - prevention & control - transmission |
2 |
|
intervention studies |
2 |
|
language development disorders - etiology - psychology |
2 |
|
log-gamma distribution |
2 |
|
masks |
2 |
|
mathematical modelling |
2 |
|
mathematical models |
2 |
|
medicine, chinese traditional - utilization |
2 |
|
mental health |
2 |
|
meta-analysis |
2 |
|
methodology |
2 |
|
multilingualism |
2 |
|
national health programs - economics |
2 |
|
neoplasms - epidemiology - ethnology |
2 |
|
nosocomial |
2 |
|
obesity - complications |
2 |
|
obesity, abdominal - epidemiology - etiology - immunology |
2 |
|
organizational case studies |
2 |
|
outbreak |
2 |
|
pandemic influenza (pandemic flu) |
2 |
|
paternal age |
2 |
|
patient acceptance of health care - ethnology |
2 |
|
patient acceptance of health care - statistics & numerical data |
2 |
|
phq-9 |
2 |
|
privatization - economics |
2 |
|
problem-based learning |
2 |
|
program evaluation - methods |
2 |
|
progressivity |
2 |
|
prophylaxis |
2 |
|
psychology, social |
2 |
|
quality of life |
2 |
|
quarantine - methods |
2 |
|
research design |
2 |
|
rutter score |
2 |
|
second-hand smoke |
2 |
|
self care |
2 |
|
self-esteem |
2 |
|
severe acute respiratory syndrome - diagnosis - epidemiology - prevention & control |
2 |
|
severe acute respiratory syndrome - epidemiology - prevention & control - transmission |
2 |
|
sexual development - immunology |
2 |
|
socio-economic position |
2 |
|
sociology, medical |
2 |
|
south korea |
2 |
|
systematic review |
2 |
|
taiwan |
2 |
|
traditional medicine |
2 |
|
treatment |
2 |
|
truncated distributions |
2 |
|
tuberculosis - complications - epidemiology |
2 |
|
ventilation |
2 |
|
ventilation - standards |
2 |
|
western allopathic medications |
2 |
|
addiction |
1 |
|
albuminuria |
1 |
|
albuminuria - epidemiology - urine |
1 |
|
all-cause mortality |
1 |
|
alzheimer disease |
1 |
|
alzheimer disease - economics - therapy |
1 |
|
angiotensin-converting enzyme inhibitors - therapeutic use |
1 |
|
anti-bacterial agents - economics - therapeutic use |
1 |
|
bacteria - isolation & purification |
1 |
|
breast neoplasms - epidemiology - prevention & control |
1 |
|
caregivers - economics |
1 |
|
cause-specific mortality |
1 |
|
climate change |
1 |
|
colonoscopy - economics - methods |
1 |
|
colony count, microbial |
1 |
|
colorectal neoplasms - epidemiology - prevention & control |
1 |
|
communicable disease control |
1 |
|
communicable diseases, emerging |
1 |
|
communication |
1 |
|
comorbidity |
1 |
|
comparative analysis |
1 |
|
confucianism |
1 |
|
cost of illness |
1 |
|
cost savings |
1 |
|
cross infection - prevention & control |
1 |
|
diabetes mellitus, type 2 - complications - urine |
1 |
|
diabetic macular oedema |
1 |
|
diabetic nephropathies |
1 |
|
diabetic nephropathies - prevention & control - urine |
1 |
|
diabetic retinopathy - drug therapy - physiopathology |
1 |
|
diagnostic screen |
1 |
|
disease transmission, infectious - statistics & numerical data |
1 |
|
economics |
1 |
|
efficiency, organizational |
1 |
|
formularies, hospital |
1 |
|
fovea centralis - pathology |
1 |
|
genomics |
1 |
|
gini |
1 |
|
gloves, protective - utilization |
1 |
|
glucocorticoids - administration & dosage - therapeutic use |
1 |
|
great britain |
1 |
|
hand - microbiology |
1 |
|
handwashing - standards |
1 |
|
health care costs |
1 |
|
health plan implementation |
1 |
|
health system |
1 |
|
healthcare disparities |
1 |
|
hemoglobin a, glycosylated - analysis |
1 |
|
hospital bed capacity, 500 and over |
1 |
|
hospitals, public - economics - statistics & numerical data |
1 |
|
hospitals, teaching |
1 |
|
human rights |
1 |
|
hypertension - drug therapy - urine |
1 |
|
individualized medicine |
1 |
|
information dissemination - methods |
1 |
|
injections |
1 |
|
intensive care units - utilization |
1 |
|
laser coagulation |
1 |
|
leadership |
1 |
|
liver transplantation - economics |
1 |
|
macular edema - drug therapy - physiopathology |
1 |
|
maladaptive internet use |
1 |
|
mammography - economics - methods |
1 |
|
mass screening - economics - organization & administration |
1 |
|
medicine in literature |
1 |
|
noninsulin-dependent |
1 |
|
occult blood |
1 |
|
ophthalmology - manpower |
1 |
|
outpatients |
1 |
|
patient compliance |
1 |
|
patient selection |
1 |
|
periodicals as topic |
1 |
|
personnel, hospital |
1 |
|
pharmaceutical preparations - economics |
1 |
|
physician's practice patterns - economics |
1 |
|
politics |
1 |
|
population growth |
1 |
|
primary schools -- china -- hong kong -- congresses. |
1 |
|
program evaluation |
1 |
|
public health - economics |
1 |
|
public health - education - methods |
1 |
|
publishing - standards |
1 |
|
recurrence |
1 |
|
retinal thickening |
1 |
|
risk management |
1 |
|
state medicine |
1 |
|
state medicine - standards |
1 |
|
tomography, optical coherence |
1 |
|
triamcinolone acetonide |
1 |
|
triamcinolone acetonide - administration & dosage - therapeutic use |
1 |
|
unnecessary procedures - economics - statistics & numerical data |
1 |
|
uterine cervical neoplasms - epidemiology - prevention & control |
1 |
|
vaginal smears - economics - methods |
1 |
|
virtues |
1 |
|
visual acuity |
1 |
|
visual acuity - physiology |
1 |
|
vitreous body |
1 |
|
women's health - economics |
1 |
